Bolus Injectors Sales

Bolus Injectors Sales Market Outlook

The global bolus injectors market is anticipated to reach USD 2.5 billion by 2035, growing at a CAGR of approximately 8.2% during the forecast period of 2025 to 2035. This growth is driven by the increasing prevalence of chronic diseases such as diabetes and the rising demand for efficient drug delivery systems. Additionally, advancements in technology, including the development of smart injectors and wearable devices, are further augmenting market growth. The rising awareness among patients regarding self-administration of medications is also expected to contribute significantly to the market expansion. Moreover, an increasing geriatric population that requires consistent and precise medication administration is expected to drive demand for bolus injectors in various healthcare settings.

Growth Factor of the Market

The bolus injectors market is experiencing significant growth due to several key factors that are shaping the industry landscape. Firstly, the rise in chronic diseases, particularly diabetes, has created a pressing need for reliable and efficient medication delivery methods. As more individuals are diagnosed with diabetes, the demand for bolus injectors—especially smart and automatic varieties—has increased substantially, facilitating personalized treatment plans. Furthermore, technological advancements in drug delivery systems, such as electronic and connected bolus injectors, have enhanced patient compliance and ease of use. In addition, the increasing focus on home healthcare and outpatient services has led to a surge in demand for devices that allow self-administration of medication. This trend is compounded by growing investments in healthcare technology, enabling the development of innovative bolus injectors. Lastly, the expansion of online pharmacies has improved accessibility to these products, making them more readily available to patients worldwide.

Key Highlights of the Market

• The bolus injectors market is projected to grow at a CAGR of 8.2% from 2025 to 2035.
• Smart bolus injectors are gaining popularity due to their ability to provide precise dosing and real-time feedback.
• Diabetes management is the leading application segment, accounting for a significant market share.
• North America holds the largest share of the bolus injectors market, driven by advanced healthcare infrastructure.
• Technological advancements are expected to fuel innovation in bolus injector designs and functionalities.

By Product Type

Disposable Bolus Injectors:

Disposable bolus injectors are primarily designed for single-use, which ensures reduced risk of cross-contamination and infection. Their convenience and ease of use make them particularly appealing in clinical settings, where quick administration of medication is often necessary. The disposable nature also alleviates the need for cleaning and maintenance, resulting in lower operational costs for healthcare providers. The increasing focus on infection control and patient safety has further propelled the demand for disposable injectors. As healthcare professionals continue to seek efficient solutions for drug delivery, the disposable bolus injectors segment is expected to witness notable growth in the coming years, offering a practical and hygienic option for medication administration.

Reusable Bolus Injectors:

Reusable bolus injectors provide a sustainable option, minimizing waste generation and costs associated with repeated purchases of disposable devices. These injectors are designed for multiple uses and can be easily cleaned and maintained, making them a cost-effective choice for patients who require long-term medication management, such as those with chronic conditions. The ability to customize dosing and settings, along with their durability, contributes to their growing popularity among patients and healthcare providers alike. Additionally, advancements in material technology have improved the longevity and functionality of reusable injectors, further enhancing their market appeal. As patients increasingly seek sustainable healthcare solutions, the reusable bolus injector segment is anticipated to gain traction in the upcoming years.

Smart Bolus Injectors:

Smart bolus injectors represent the cutting edge of drug delivery technology, integrating digital health features such as mobile app connectivity, real-time monitoring, and data analytics. These injectors offer patients the ability to track their medication usage, receive reminders, and share data with healthcare providers, facilitating better management of chronic diseases. The increasing adoption of smart injectors is driven by the growing trend of personalized medicine and patient-centric care, as they allow for tailored treatment plans based on individual needs. Moreover, the ability to provide alerts for missed doses and feedback on injection techniques enhances patient compliance, making smart bolus injectors an essential tool in modern healthcare. As technology continues to evolve, the smart bolus injector segment is expected to witness the most substantial growth within the market.

Manual Bolus Injectors:

Manual bolus injectors offer a traditional method for medication delivery, requiring patients or healthcare professionals to administer doses manually. While they may not include advanced features found in electronic or smart injectors, manual bolus injectors are valued for their simplicity and reliability. They are often used in settings where technology integration is limited or where users prefer a straightforward approach to medication administration. The manual bolus injectors market continues to hold relevance, particularly in regions with lower access to advanced healthcare technologies. Although growth may be slower compared to automated options, the manual injectors segment remains an essential component of the overall bolus injectors market.

Automatic Bolus Injectors:

Automatic bolus injectors streamline the medication delivery process by automating key functions, which enhances efficiency and reduces the likelihood of user error. These devices are particularly beneficial for patients with conditions that require precise dosing, ensuring accurate medication administration without extensive user intervention. The convenience offered by automatic injectors has made them increasingly popular among patients and healthcare providers alike. Additionally, their integration with smart technologies allows for seamless data sharing and tracking, thereby improving patient outcomes. As a result, the automatic bolus injector segment is poised for growth as healthcare systems prioritize accuracy and efficiency in drug delivery methods.

By Application

Diabetes Management:

Diabetes management remains the leading application for bolus injectors, driven by the growing prevalence of diabetes worldwide. Bolus injectors facilitate the precise administration of insulin, which is critical for managing blood glucose levels in patients with diabetes. The rise in the diabetic population, particularly among older adults, has led to increased demand for effective drug delivery solutions. Additionally, educational initiatives aimed at improving patient awareness regarding self-administration techniques have contributed to the market's growth. With the integration of technology into diabetes management, including smart injectors that track glucose levels and provide real-time feedback, this segment is expected to continue its upward trajectory in the coming years.

Anaphylaxis Treatment:

Bolus injectors are also utilized for the treatment of anaphylaxis, where rapid administration of epinephrine is crucial for patient survival. The increasing incidence of severe allergic reactions has heightened the need for efficient delivery systems that can be used in emergency situations. Bolus injectors provide a reliable method for delivering anaphylaxis treatments swiftly, which is essential for improving patient outcomes. As awareness of anaphylaxis and its triggers grows among the public, more individuals are carrying auto-injectors and bolus devices for immediate use. Consequently, the anaphylaxis treatment application segment is expected to experience steady growth, driven by rising awareness and the need for quick intervention.

Pain Management:

The pain management application of bolus injectors focuses on the administration of analgesics and anesthetics for various medical conditions. With the increasing prevalence of chronic pain disorders and the need for effective pain relief solutions, bolus injectors have emerged as an effective delivery method. These devices facilitate the accurate dosing of medications, which is essential for managing pain effectively, particularly in surgical and post-operative settings. The convenience of bolus injectors enables healthcare providers to administer medications seamlessly, enhancing patient comfort and recovery. As the demand for effective pain management solutions continues to rise, this segment is poised for further growth.

Oncology:

In the field of oncology, bolus injectors play a crucial role in delivering chemotherapy agents and supportive care medications. The ability to administer precise dosages is vital in oncology treatment, where the therapeutic window can be narrow and patient responses vary significantly. Bolus injectors enable healthcare professionals to tailor treatment regimens to individual patient needs, thereby optimizing therapeutic outcomes. Additionally, the growing emphasis on personalized medicine in oncology is driving advances in drug delivery technologies, which further enhances the role of bolus injectors in cancer care. As innovations continue to evolve, the oncology application segment is expected to expand, bolstered by advancements in treatment approaches.

By Distribution Channel

Hospitals:

Hospitals represent a significant distribution channel for bolus injectors, accounting for a considerable share of the market. Given the high patient volumes and the critical nature of treatment administered in hospital settings, the demand for bolus injectors is substantial. Hospitals utilize a comprehensive range of bolus injectors across various departments, including emergency care, surgery, and outpatient clinics. The availability of advanced medical technologies in hospitals further enhances the integration of bolus injectors into patient care protocols. As hospitals continue to prioritize patient safety and effective medication administration, the reliance on bolus injectors is expected to grow, solidifying their role in hospital settings.

Retail Pharmacies:

Retail pharmacies serve as a vital distribution channel for bolus injectors, allowing patients to access medication delivery devices conveniently. The rise in patient self-management of chronic conditions has driven increased sales of bolus injectors through retail outlets, as individuals seek to purchase devices for home use. Retail pharmacies also play a crucial role in educating patients about the proper use of bolus injectors, thereby enhancing compliance and efficacy. As the trend of self-administration of medications continues to rise, retail pharmacies are expected to experience considerable growth in the bolus injectors market, catering to the evolving needs of health-conscious consumers.

Online Pharmacies:

The emergence of online pharmacies has transformed the distribution landscape for bolus injectors, offering patients greater accessibility and convenience. With the increasing trend of e-commerce in healthcare, patients can now easily order bolus injectors from the comfort of their homes. Online pharmacies often provide a wide variety of products, including specialty bolus injectors, which may not be readily available in physical locations. Additionally, the convenience of online shopping and the ability to compare prices are appealing factors driving this segment's growth. As more consumers embrace online purchasing for healthcare products, online pharmacies are likely to become a dominant distribution channel in the bolus injectors market.

Others:

Other distribution channels encompass a range of options, including specialized medical supply stores and direct sales from manufacturers. These channels cater to niche markets and specific customer segments that may seek bolus injectors for unique applications or requirements. For instance, manufacturers may offer direct sales to healthcare institutions or home healthcare providers, ensuring a steady supply of their products. Additionally, specialized medical supply stores often stock a variety of bolus injectors, providing patients with tailored options based on their specific needs. Although this segment may not be as prominent as the primary distribution channels, it serves an essential role in meeting diverse customer demands.

By Technology

Mechanical Bolus Injectors:

Mechanical bolus injectors rely on simple mechanical components to administer medication, offering a reliable and straightforward method for drug delivery. These injectors are designed for ease of use, making them suitable for various medical applications, including chronic disease management and emergency treatments. The simplicity of mechanical injectors ensures minimal maintenance and operational costs, providing an economical solution for healthcare providers. While they may lack advanced features found in electronic models, the robustness and reliability of mechanical bolus injectors maintain their relevance in the market. As healthcare continues to evolve, mechanical bolus injectors will remain a vital component of medication delivery systems.

Electronic Bolus Injectors:

Electronic bolus injectors leverage advanced technology to enhance the accuracy and efficiency of medication delivery. These devices are commonly equipped with features such as programmable dosing, safety alarms, and user-friendly interfaces, making them ideal for a range of applications. Their integration into clinical practices facilitates precise medication administration, reducing the potential for dosing errors. As the healthcare landscape shifts towards technology-driven solutions, electronic bolus injectors are expected to witness significant growth, driven by the increasing focus on patient safety and enhanced treatment outcomes. The capability of these injectors to provide real-time data monitoring further positions them as essential tools in modern healthcare delivery.

Wearable Bolus Injectors:

Wearable bolus injectors are an innovative solution for continuous medication delivery, particularly in managing chronic conditions like diabetes. These devices can be worn on the body, allowing for discreet medication administration without interfering with daily activities. Wearable injectors enhance patient compliance by providing a convenient option for medication delivery, reducing the burden of frequent injections. Furthermore, advancements in wearable technology enable integration with mobile apps, facilitating real-time monitoring and data sharing with healthcare providers. As the demand for patient-centric solutions continues to grow, the market for wearable bolus injectors is expected to expand significantly.

Connected Bolus Injectors:

Connected bolus injectors represent the next generation of drug delivery devices, integrating digital health technology for enhanced patient engagement and monitoring. These devices allow for seamless connectivity with mobile applications, enabling patients to track their medication usage, receive alerts, and share vital health information with their healthcare teams. The connectivity feature empowers patients to take charge of their treatment, improving adherence and overall health outcomes. As healthcare continues to embrace digital solutions, connected bolus injectors are poised for substantial growth, driven by the increasing emphasis on personalized medicine and telehealth services. Their ability to facilitate remote patient monitoring further solidifies their importance in contemporary healthcare practices.

By Region

The North American bolus injectors market commands a significant share due to advanced healthcare infrastructure, high prevalence of chronic diseases, and robust adoption of innovative technologies. The region is home to leading pharmaceutical companies and medical device manufacturers, driving innovation and product availability. With the increasing emphasis on patient-centered care and self-administration of medications, North America is expected to maintain its dominance in the bolus injectors market throughout the forecast period. Furthermore, the market in North America is projected to expand at a CAGR of approximately 8.6%, reflecting the continuous growth in demand for efficient drug delivery systems.

In Europe, the bolus injectors market is also experiencing considerable growth, fueled by the rising incidence of chronic diseases and the aging population. The region has witnessed an increase in healthcare expenditure, which has led to the incorporation of advanced medical technologies in treatment protocols. Countries such as Germany, France, and the United Kingdom are leading the way in the adoption of bolus injectors, driven by a focus on improving patient outcomes. The European market is expected to grow steadily, supported by the regulatory environment that encourages innovation and the introduction of new products. However, the growth rate may be slightly lower than in North America, reflecting regional differences in healthcare practices and patient preferences.

Opportunities

The bolus injectors market is poised for significant opportunities, particularly through the integration of advanced technologies that enhance usability and patient outcomes. As healthcare systems increasingly adopt telemedicine and remote patient monitoring solutions, bolus injectors equipped with connectivity features are gaining traction. These smart devices enable real-time data sharing between patients and healthcare providers, allowing for timely interventions and personalized treatment plans. Moreover, the growing trend of home healthcare presents a substantial opportunity for bolus injectors, as patients seek reliable and easy-to-use devices for self-medication. With the aging population and the rise of chronic diseases, the demand for efficient drug delivery systems is expected to surge, paving the way for innovative bolus injector solutions in the market.

Another promising opportunity lies within the expansion of emerging markets. Regions such as Asia Pacific and Latin America are witnessing rapid economic growth and healthcare development, resulting in increased access to medical technologies. As these regions become more invested in improving healthcare infrastructure, the demand for bolus injectors is expected to rise. Furthermore, through partnerships with local distributors and healthcare organizations, manufacturers can tap into these growing markets, providing essential products that cater to the unique needs of patients. By focusing on these emerging opportunities, bolus injector manufacturers can position themselves for long-term success and play a vital role in addressing the global healthcare challenges.

Threats

While the bolus injectors market presents numerous opportunities, it also faces certain threats that could hinder growth. One major concern is the increasing competition from alternative drug delivery systems, such as oral medications and advanced infusion pumps, which may offer similar benefits and convenience. As new technologies emerge, patients might gravitate toward alternatives that provide enhanced experiences or lower costs, placing pressure on bolus injector manufacturers to innovate continually. Additionally, fluctuations in regulatory environments could pose challenges, as manufacturers must navigate varying compliance requirements across different regions. The competitive landscape remains dynamic, and companies need to adapt swiftly to changing market conditions to maintain their position in the industry.

Moreover, the bolus injectors market is susceptible to external economic factors, such as inflation and shifts in healthcare funding. Budgetary constraints in public health systems can restrict access to advanced medical devices, limiting the adoption of bolus injectors. Economic downturns may lead to reduced consumer spending on healthcare products, impacting the overall demand for bolus injectors. Additionally, supply chain disruptions resulting from geopolitical tensions or global crises could affect the availability of components needed for bolus injector production. Manufacturers must remain vigilant and develop strategies to mitigate these risks, ensuring that they can sustain growth in this competitive landscape.

Competitor Outlook

• Medtronic
• BD (Becton, Dickinson and Company)
• Insulet Corporation
• Ypsomed AG
• Roche Diagnostics
• Amgen Inc.
• SmartDose
• Terumo Corporation
• GSK (GlaxoSmithKline)
• Janssen Pharmaceuticals
• Horizon Therapeutics
• Abbott Laboratories
• Fresenius Kabi
• Novartis AG
• Johnson & Johnson

The competitive landscape of the bolus injectors market is characterized by a diverse range of players, each contributing to the development and innovation of drug delivery systems. Major companies are focused on enhancing product offerings by incorporating advanced technologies such as connectivity features and smart functionalities. These enhancements aim to improve patient experience and compliance, which are critical factors in the effectiveness of medication management. Additionally, companies are investing in research and development to explore new materials and designs that can facilitate better drug delivery methods. As the market evolves, collaboration and partnerships are also becoming prevalent, allowing companies to leverage each other's strengths and expand their market reach.

Medtronic, a leading player in the bolus injectors market, is renowned for its innovative approach to diabetes management. The company's insulin delivery systems, including insulin pumps and smart injectors, are designed to provide patients with precise and customizable treatment options. With a strong focus on research and development, Medtronic continues to invest in cutting-edge technology that enhances the effectiveness of its products. Furthermore, its robust distribution network ensures that patients have access to essential medical devices, reinforcing its position as a market leader.

Another notable competitor, BD (Becton, Dickinson and Company), has established itself as a key player in the medical device industry, offering a wide range of bolus injectors. The company's commitment to improving healthcare outcomes through innovation positions it favorably in the market. BD's extensive experience in drug delivery systems and its emphasis on safety and efficiency make it a trusted choice for healthcare providers. Furthermore, BD's global presence enables it to reach a diverse customer base, further solidifying its market position.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 SmartDose
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Amgen Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Ypsomed AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Novartis AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Insulet Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Horizon Therapeutics
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 GSK (GlaxoSmithKline)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Janssen Pharmaceuticals
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bolus Injectors Sales Market, By Technology
    • 6.1.1 Mechanical Bolus Injectors
    • 6.1.2 Electronic Bolus Injectors
    • 6.1.3 Wearable Bolus Injectors
    • 6.1.4 Connected Bolus Injectors
    • 6.1.5 Others
  • 6.2 Bolus Injectors Sales Market, By Application
    • 6.2.1 Diabetes Management
    • 6.2.2 Anaphylaxis Treatment
    • 6.2.3 Pain Management
    • 6.2.4 Oncology
    • 6.2.5 Others
  • 6.3 Bolus Injectors Sales Market, By Product Type
    • 6.3.1 Disposable Bolus Injectors
    • 6.3.2 Reusable Bolus Injectors
    • 6.3.3 Smart Bolus Injectors
    • 6.3.4 Manual Bolus Injectors
    • 6.3.5 Automatic Bolus Injectors
  • 6.4 Bolus Injectors Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Bolus Injectors Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bolus Injectors Sales market is categorized based on

By Product Type

• Disposable Bolus Injectors
• Reusable Bolus Injectors
• Smart Bolus Injectors
• Manual Bolus Injectors
• Automatic Bolus Injectors

By Application

• Diabetes Management
• Anaphylaxis Treatment
• Pain Management
• Oncology
• Others

By Distribution Channel

• Hospitals
• Retail Pharmacies
• Online Pharmacies
• Others

By Technology

• Mechanical Bolus Injectors
• Electronic Bolus Injectors
• Wearable Bolus Injectors
• Connected Bolus Injectors
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• BD (Becton, Dickinson and Company)
• Insulet Corporation
• Ypsomed AG
• Roche Diagnostics
• Amgen Inc.
• SmartDose
• Terumo Corporation
• GSK (GlaxoSmithKline)
• Janssen Pharmaceuticals
• Horizon Therapeutics
• Abbott Laboratories
• Fresenius Kabi
• Novartis AG
• Johnson & Johnson